Prognostic Nomogram of Prognosis-Related Genes and Clinicopathological Characteristics to Predict the 5-Year Survival Rate of Colon Cancer Patients

被引：21

作者：

Huang, Chao ^{[1
]}

Zhao, Jiefeng ^{[1
]}

Zhu, Zhengming ^{[1
]}

机构：

[1] Nanchang Univ, Dept Gastrointestinal Surg, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China

来源：

FRONTIERS IN SURGERY | 2021年 / 8卷

基金：

中国国家自然科学基金;

关键词：

colon cancer; prognostic genes; clinicopathological characteristics; overall survival; nomogram; LONG NONCODING RNAS; CURATIVE COLECTOMY; EXPRESSION; PSEUDOGENES; RECURRENCE;

D O I：

10.3389/fsurg.2021.681721

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Background: The Cancer Genome Atlas (TCGA) has established a genome-wide gene expression profile, increasing our understanding of the impact of tumor heredity on clinical outcomes. The aim of this study was to construct a nomogram using data from the TCGA regarding prognosis-related genes and clinicopathological characteristics to predict the 5-years survival rate of colon cancer (CC) patients. Methods: Kaplan-Meier and Cox regression analyses were used to identify genes associated with the 5-years survival rate of CC patients. Cox regression was used to analyze the relationship between the clinicopathological features and prognostic genes and overall survival rates in patients with CC and to identify independent risk factors for the prognosis of CC patients. A nomogram for predicting the 5-years survival rate of CC patients was constructed by R software. Results: A total of eight genes (KCNJ14, CILP2, ATP6V1G2, GABRD, RIMKLB, SIX2, PLEKHA8P1, and MPP2) related to the 5-years survival of rate CC patients were identified. Age, stage, and PLEKHA8P1 were independent risk factors for the 5-years survival rate in patients with CC. The accuracy, sensitivity and specificity of the nomogram model constructed by age, TNM staging, and PLEKHA8P1 for predicting the 5-years survival of rate CC patients were 83.3, 83.97, and 85.79%, respectively. Conclusion: The nomogram can correctly predict the 5-year survival rate of patients with CC, thus aiding the individualized decision-making process for patients with CC.

引用

页数：9

共 43 条

[1] Discrimination and Calibration of Clinical Prediction Models Users' Guides to the Medical Literature [J].

Alba, Ana Carolina ;

Agoritsas, Thomas ;

Walsh, Michael ;

Hanna, Steven ;

Iorio, Alfonso ;

Devereaux, P. J. ;

McGinn, Thomas ;

Guyatt, Gordon .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (14) :1377-1384

[2] miRNA, Development and Disease [J].

Amiel, Jeanne ;

de Pontual, Loic ;

Henrion-Caude, Alexandra .

ADVANCES IN GENETICS, VOL 80, 2012, 80 :1-36

[3] Prognosis of stage II colon cancer by non-neoplastic mucosa gene expression profiling [J].

Barrier, A. ;

Roser, F. ;

Boelle, P-Y ;

Franc, B. ;

Tse, C. ;

Brault, D. ;

Lacaine, F. ;

Houry, S. ;

Callard, P. ;

Penna, C. ;

Debuire, B. ;

Flahault, A. ;

Dudoit, S. ;

Lemoine, A. .

ONCOGENE, 2007, 26 (18) :2642-2648

[4] Stage II colon cancer prognosis prediction by tumor gene expression profiling [J].

Barrier, Alain ;

Boelle, Pierre-Yves ;

Roser, Francois ;

Gregg, Jennifer ;

Tse, Chantal ;

Brault, Didier ;

Lacaine, Francois ;

Houry, Sidney ;

Huguier, Michel ;

Franc, Brigitte ;

Flahault, Antoine ;

Lemoine, Antoinette ;

Dudoit, Sandrine .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (29) :4685-4691

[5]

Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]

[6] New insights into long noncoding RNAs and pseudogenes in prognosis of renal cell carcinoma [J].

Chen, Binghai ;

Wang, Chengyue ;

Zhang, Jin ;

Zhou, Yang ;

Hu, Wei ;

Guo, Tao .

CANCER CELL INTERNATIONAL, 2018, 18

[7] Downregulated pseudogene CTNNAP1 promote tumor growth in human cancer by downregulating its cognate gene CTNNA1 expression [J].

Chen, Xiangjian ;

Zhu, Hua ;

Wu, Xiaoli ;

Xie, Xuemeng ;

Huang, Guanli ;

Xu, Xiaoqun ;

Li, Shi ;

Xing, Chungen .

ONCOTARGET, 2016, 7 (34) :55518-55528

[8] Comprehensive genomic characterization defines human glioblastoma genes and core pathways [J].

Chin, L. ;

Meyerson, M. ;

Aldape, K. ;

Bigner, D. ;

Mikkelsen, T. ;

VandenBerg, S. ;

Kahn, A. ;

Penny, R. ;

Ferguson, M. L. ;

Gerhard, D. S. ;

Getz, G. ;

Brennan, C. ;

Taylor, B. S. ;

Winckler, W. ;

Park, P. ;

Ladanyi, M. ;

Hoadley, K. A. ;

Verhaak, R. G. W. ;

Hayes, D. N. ;

Spellman, Paul T. ;

Absher, D. ;

Weir, B. A. ;

Ding, L. ;

Wheeler, D. ;

Lawrence, M. S. ;

Cibulskis, K. ;

Mardis, E. ;

Zhang, Jinghui ;

Wilson, R. K. ;

Donehower, L. ;

Wheeler, D. A. ;

Purdom, E. ;

Wallis, J. ;

Laird, P. W. ;

Herman, J. G. ;

Schuebel, K. E. ;

Weisenberger, D. J. ;

Baylin, S. B. ;

Schultz, N. ;

Yao, Jun ;

Wiedemeyer, R. ;

Weinstein, J. ;

Sander, C. ;

Gibbs, R. A. ;

Gray, J. ;

Kucherlapati, R. ;

Lander, E. S. ;

Myers, R. M. ;

Perou, C. M. ;

McLendon, Roger .

NATURE, 2008, 455 (7216) :1061-1068

[9] Colorectal cancer [J].

Dekker, Evelien ;

Tanis, Pieter J. ;

Vleugels, Jasper L. A. ;

Kasi, Pashtoon M. ;

Wallace, Michael B. .

LANCET, 2019, 394 (10207) :1467-1480

[10] The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM [J].

Edge, Stephen B. ;

Compton, Carolyn C. .

ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (06) :1471-1474

← 1 2 3 4 5 →